Eloxx Pharmaceuticals, a Waltham, Massachusetts-based clinical-stage biopharmaceutical company, has appointed Robert Ward as chairman of the board of directors of Eloxx and chief executive officer (CEO), effective December 27, 2017.  Ward succeeds outgoing Chairman of the Board, Robert Heft, and current founder and CEO Dr. Silvia Noiman.

Ward has more than 30 years of experience in the biopharmaceutical industry, including in drug development, commercialization, and strategic business development transactions. Ward was most recently the president and CEO of Radius Health, a Waltham, Massachusetts-headquartered biopharmaceutical company.

Source: Eloxx Pharmaceuticals